Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
135.68
+1.68 (1.25%)
At close: Nov 19, 2026, 4:00 PM EST
133.78
-1.90 (-1.40%)
After-hours: Nov 19, 2026, 5:09 PM EST
Axsome Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $249 → $223 | Hold | Maintains | $249 → $223 | +64.36% | Nov 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $290 | Buy | Reiterates | $290 | +113.74% | Nov 9, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $284 → $272 | Buy | Maintains | $284 → $272 | +100.47% | Nov 4, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $267 → $245 | Buy | Maintains | $267 → $245 | +80.57% | Nov 3, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Initiates $300 | Buy | Initiates | $300 | +121.11% | Nov 3, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $272 | Buy | Maintains | $272 | +100.47% | Nov 3, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $256 | Buy | Reiterates | $256 | +88.68% | Nov 3, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $275 → $250 | Buy | Maintains | $275 → $250 | +84.26% | Nov 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.